Suresh K. Durgam, EVP, Chief Medical Officer: Intra-Cellular Therapies ITCI Sell · Filed 23/07/20

Trade details

Type: Insider sale
Amount: $119,730
Shares · price: 1,842 sh · $65.00 a share
Held after: 21,262 sh
Stock: Intra-Cellular Therapies ITCI
Person: Suresh K. DurgamEVP, Chief Medical Officer
Trade date: 23/07/17
Filed: 23/07/20
Days to filing: 3 days

Sold 8.0% of holdings

Share of holding sold: 8.0%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 23/06/17~23/08/16

Suresh K. Durgam's recent trades

Suresh K. DurgamEVP, Chief Medical Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$247.3K
3,728 sh
$247.3K
Filed 24/03/11
Traded 24/03/07
Suresh K. DurgamEVP, Chief Medical Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$182K
2,722 sh
$182K
Filed 24/03/11
Traded 24/03/07
Suresh K. DurgamEVP, Chief Medical Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$141.8K
2,179 sh
$141.8K
Filed 24/03/11
Traded 24/03/11
Suresh K. DurgamEVP, Chief Medical Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$57.5K
872 sh
$57.5K
Filed 24/03/11
Traded 24/03/11
Suresh K. DurgamEVP, Chief Medical Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$44.3K
661 sh
$44.3K
Filed 24/03/11
Traded 24/03/11